INCENDIA THERAPEUTICS
Live / Applied — Non-final action mailed (as of 18 Feb 2026)
What this means for you
Not registered yet, but its 12 Dec 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98311406
- Mark type
- Stylized text
- Filed
- 12 Dec 2023
- Attorney of record
- IAN W. GILLIES
Goods and services
- Class 001 — Chemicals: Monoclonal antibodies used in industry and science, and in the manufacture of pharmaceuticals, pharmaceutical preparations and substances, for the treatment of immune-excluded tumors found in recalcitrant cancers
- Class 005 — Pharmaceuticals: Monoclonal antibody products and preparations for the treatment of immune-excluded tumors found in recalcitrant cancers; pharmaceutical products and preparations consisting of monoclonal antibodies for the treatment of immune-excluded tumors found in recalcitrant cancers; pharmaceutical preparations developed with a computational platform engine using biology and chemistry analytics for the treatment of immune-excluded tumors found in recalcitrant cancers
- Class 042 — Scientific and technological services: Drug discovery services for the discovery of monoclonal antibody-containing drugs for the treatment of immune-excluded tumors, provided through a computational platform engine using biology and chemistry analytics in the field of recalcitrant cancers
Owner
- Incendia Therapeutics Inc., Boston, MA, US
Prosecution history
- 18 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 Feb 2026 — NON-FINAL ACTION E-MAILED
- 18 Feb 2026 — NON-FINAL ACTION WRITTEN
- 22 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Jul 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 Jul 2025 — ASSIGNED TO LIE
- 17 Jul 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 17 Jul 2025 — EX PARTE APPEAL-INSTITUTED
- 17 Jul 2025 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 17 Jul 2025 — EXPARTE APPEAL RECEIVED AT TTAB
- 14 Apr 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 14 Apr 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 22 Jan 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 22 Jan 2025 — FINAL REFUSAL E-MAILED
- 22 Jan 2025 — FINAL REFUSAL WRITTEN